Security key
92790C104
Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN)
CUSIP: 92790C104
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock, $0.01 par value per share
- Total 13F shares
- 37,976,766
- Total 13F value
- $778,702,810
- Share change
- +9,583,568
- Put/Call ratio
- 26%
- SEC-reported price per share
- $20.51
- Number of holders
- 104
- Value change
- +$213,427,951
- Number of buys
- 80
- Number of sells
- 24
- Shares outstanding
- 110,466,431
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
104
Top holders
10
VRDN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Viridian Therapeutics, Inc.\DE SEC filings
Viridian Therapeutics, Inc.\DE company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92790C104
Recent filing periods:
Ownership snapshot
Top reported holders of VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Venrock Adviser, LLC
Disclosed value leader
Venrock Adviser, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 1.7%
Showing 1-6 of 15 holder rows.
Quick read
Venrock Adviser, LLC leads the comparable SEC ownership view at 1.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Venrock Adviser, LLC's linked filing trail.
Comparable ownership
Top 5
Venrock Adviser, LLC
1.7%
BVF INC/IL
1.6%
Commodore Capital LP
1.5%
BlackRock Finance, Inc.
1.3%
VANGUARD GROUP INC
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Venrock Adviser, LLC |
13F
Company
|
1.7%
|
$21,438,000
1,852,919 shares
|
— | 30 Jun 2022 |
| BVF INC/IL |
13F
Company
|
1.6%
|
$20,178,000
1,744,012 shares
|
— | 30 Jun 2022 |
| Commodore Capital LP |
13F
Company
|
1.5%
|
$18,959,000
1,638,609 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
1.3%
|
$16,462,000
1,422,824 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
1.3%
|
$16,324,000
1,410,902 shares
|
— | 30 Jun 2022 |
| TCG Crossover Management, LLC |
13F
Company
|
1.2%
|
$15,203,000
1,314,000 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
104
Shares
37,976,766
Rows available
104
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
80
Q3 2022 holders
104
Holder diff
24
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend